Gencia Looks To Improve Steroids With Takeda Deal
This article was originally published in PharmAsia News
Executive Summary
With its first collaboration on the books, Gencia CEO Allen Cunningham says the biotech is putting all its focus into developing those compounds and will look to ink further collaborations at a later date.